Research Management Group (RMG)

Global Health Funding Opportunities

This webpage contains miscellaneous global health funding opportunities.

 

index of global health funding opportunities and resources


 

 

Special announcements

 

 

 

The Pew Charitable Trusts
Pew Latin American Fellows

The Pew fellowship provides a $30,000 salary stipend in each of two years and an additional $70,000 payment to the sponsoring institution when the fellow confirms plans to return to Latin America.
Purpose: The Pew Latin American Fellows Program in the Biomedical Sciences provides funding for scientists to receive postdoctoral training at leading research institutions in the United States.
Eligibility
For the 2019 application process, applicants must have been awarded a Ph.D. and/or M.D. degree by February 2019 but not for more than five years prior to July 11, 2019. Preference will be given to applicants who received their undergraduate and graduate degrees from institutions in Latin America. Applicants may have obtained their undergraduate or graduate degrees from a school outside of Latin America but preferably not in the United States. Applicants may not have had previous postdoctoral training in the United States in excess of 18 months prior to July 11, 2019. Applicants will not be considered if they have completed graduate work with a proposed sponsor. Applicants are required to submit a written statement of intent to return to Latin America. 
Applicants must identify and confirm a postdoctoral position in the laboratory of an established principal investigator (sponsor) in advance of applying. Many excellent scientists in major research institutions in the United States are interested in having Pew Latin American fellows come to their labs for postdoctoral training. For assistance in identifying possible sponsors, potential applicants may e-mail the program office, at fellowsapp@pewtrusts.org. A list of potential postdoctoral positions can be found here.
Note: To apply, potential candidates must send an e-mail to the program office at fellowsapp@pewtrusts.org to request login info for the application portal, which will open July 11, 2018.
Deadline:  Sept. 28, 2018
http://www.pewtrusts.org/en/projects/pew-latin-american-fellows/program-details
FAQ webpage >>

 

 

American Society of Hematology
ASH Global Research Award
For projects of one year or less, the applicant may request up to $100,000
For projects of more than one year, the applicant may request up to $150,000
Eligibility: Support the hematology-focused careers of ASH members at the trainee and early investigator career stages based in countries other than the United States or Canada.
Types of projects: Hematology research, including basic, translational, patient-oriented, and outcomes-based research; Requests for training at other institutions by trainees or early-career investigators, pilot studies, collaborative projects, and other proposals for career development
Timeline:
Letter of intent (required) deadline: August 31, 2018
Invitation sent to approved applicants: Jan. 2019
Full proposal (by invitation only): April 19, 2019
http://www.hematology.org/Global-Research.aspx

 

 




Bill and melinda Gates Foundation Funding opportunities

 

 

Bill and Melinda Gates Foundation
Request for Proposal for Single-Dose, Prefilled, Dual Chamber Injection Device

Amount of funding: The focus of the Request for Proposal will be on early research and creation of prototype devices for human factor study. It is anticipated that ~3-5 awards will be made in January 2019 and range from $100K - $250K per award. Target grant duration is about 6 months.
Eligibility: faculty with PI eligibility
Purpose: This project is to design and build an initial prototype of a dual-chamber, prefilled, single-dose injection device. These devices will be required in the global health space to enable simple, intuitive reconstitution and injection of drug products that require storage in the dry state (powder or cakes) in remote in-home settings.
This Request for Proposal outlines two use cases for the device: administration of measles-rubella vaccine in house-to-house campaigns by low skilled healthcare workers and self-administration of next-generation, long-acting, injectable contraceptives by patients, themselves, in a home or other non-clinical setting.
The device should enable safe injection outside of traditional healthcare facilities and meet minimum requirements for one of the two use cases outlined. Ideally, proposed devices will meet and exceed minimum requirements for both use cases.
Timeline:
Round 1 Concept Memorandum submission deadline:  Tuesday, July 10, 2018 5pm PST
Finalists notified in mid-August
Full proposals (by invitation only) deadline: Monday, Sept. 17, 2018, 5 p.m. PST
https://www.gatesfoundation.org/How-We-Work/General-Information/Grant-Opportunities/Dual-Chamber-Injection-Device-RFP


 

Bill and Melinda Gates Foundation
Grand Challenges Explorations Round 21
The deadline has passed
Program overview webpage >>


Global Grand Challenges Explorations Award grants:
Recipient webpage >>

Grand Challenges: Campylobacter spp. Transmission Dynamics in Low to Middle Income Countries
The deadline has passed.
Guidelines >>

Grand Challenges Explorations-Brazil: Data Science Approaches to Improve Maternal and Child Health in Brazil
The deadline has passed.
Guidelines >>



 

 


 

Global Oncology (GO!)

 



Global Oncology (GO!)
Dr. Ami Bhatt, Stanford University School of Medicine, is the co-founder and co-president of GO!
http://globalonc.org/

 

Global Oncology (GO!)
The Global Cancer Project Map (GCPM)
Purpose: The Global Cancer Project Map, released on March 25, 2015, is a web-based platform that catalogs international cancer research, cancer care, and cancer outreach programs. The platform aligns cancer care efforts of governmental agencies, non-profit organizations, academic institutions and industry partners.
The creation of the Global Cancer Project Map and its potential to facilitate cancer control and research programs in resource-poor settings have been a result of an alliance between Global Oncology, Inc. and the National Cancer Institute’s Center for Global Health. Thanks to the database expertise and content standards provided by the National Cancer Institute, a component of the National Institutes of Health and an agency of the U.S. Department of Health and Human Services, the Global Cancer Project Map provides resources to partners across the world to address the challenges of cancer and reduce cancer-related deaths.
Objectives: The GCPM’s primary objectives are to:
- Facilitate the breaking down of silos and building of collaboration
-Accelerate progress, ensure a balanced investment of resources, and align global cancer care and cancer efforts
-Provide resources to view and better understand international efforts in cancer research and control
Special thanks to the Center for Global Health National Cancer Institute, U.S.A.
Website:
http://globalonc.org/Projects/global-cancer-project-map/

 





NIH Global Health Funding Opportunities

 

    • Bioethics training program more >>

    • Cancer related programs more >>

    • Career Development Program-U.S. researchers more >>

    • Career Development Program for investigators in LMIC countries more >>

    • Conference and Scientific Meetings (NIH Parent R13) more >>

    • Dissemination and Implementation Research in Health (FIC is participating) more >>

    • HIV more >>

    • Infectious diseases: more >>

    • Indo-U.S. Vaccine Action Program more >>

    • Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21) (PAR-16-292) *reissued*

    • Neuroscience: NIH Global Brain and Nervous System Disorders Research Across the Lifespan more >>

    • Pulmonary non-tuberculous mycobacterial infection more >>

    • Simulation Modeling and Systems Science to Address Health Disparities more >>

    • Tobacco use and HIV in Low and Middle Income Countries (R21) more >>

    • Zika Virus more >>

    • Institutional representatives (RPM/RMG or OSR) and Internal Proposal Deadline policy more >> Funding Email lists

 

 



Bioethics Training Program

 

 

International Bioethics Research Training Program (D43) (PAR-16-454)  *reissued*
John E. Fogarty International Center
FIC will support LMIC-U.S. collaborative institutional bioethics doctoral and postdoctoral research training programs that incorporate didactic, mentored research and training components to prepare a number of individuals with ethics expertise for positions of scholarship and leadership in health research institutions in the LMIC.
See the guidelines for eligibility criteria, etc.
Remaining application Receipt/Submission Date(s): May 17, 2018
Guidelines:
http://grants.nih.gov/grants/guide/pa-files/PAR-16-454.html


 

Cancer related programs

 

 

See the NIH Support for Conferences and Scientific Meetings (Parent R13) PAR-18-648 below >>







Career development award for u.s. researchers


 

NIH International Research Scientist Development Award (IRSDA) (Independent Clinical Trial Not Allowed) (K01) (PAR-18-539)
John E. Fogarty International Center
National Cancer Institute
Stanford Eligibility clarification**:
--Advanced postdoctoral U.S. research scientists, and recently-appointed U.S. junior faculty ( assistant professors with PI eligiblity and CE assistant professors-with an approved CE faculty PI waiver) Applicants must be at least two years beyond conferral of doctoral degree)
--Stanford Instructors, and Academic Staff Researchers are also eligible per the NIH program official.
Purpose:
The purpose of the International Research Scientist Development Award (IRSDA) is to provide support and protected time (three to five years) to advanced postdoctoral U.S. research scientists, Instructors**, and Academic Staff Researchers** and recently-appointed U.S. junior faculty (at least two years beyond conferral of doctoral degree) for an intensive, mentored research career development experience in a low- or middle-income country (LMIC) leading to an independently funded research career focused on global health. FIC invites applications from early-career investigators from any health related discipline who propose career development activities and a research project that is relevant to the health priorities of the LMIC.
See the guidelines for additional eligibility criteria
Remaining Application Receipt/Submission Date(s): March 7, 2019, March 6, 2020 by 5:00 PM local time of applicant organization.
Guidelines:
https://grants.nih.gov/grants/guide/pa-files/PAR-18-539.html

 

 

NIH International Research Scientist Development Award (IRSDA) (Independent Clinical Trial Required) (K01) (PAR-18-540)
John E. Fogarty International Center
National Cancer Institute
Stanford Eligibility clarification**:
--Advanced postdoctoral U.S. research scientists, and recently-appointed U.S. junior faculty (assistant professors with PI eligiblity and CE assistant professors (with an approved CE faculty PI waiver). Applicants must be at least two years beyond conferral of doctoral degree)
--Stanford Instructors, and Academic Staff Researchers are also eligible per the NIH program official.
Purpose:
The purpose of the International Research Scientist Development Award (IRSDA) is to provide support and protected time (three to five years) to advanced postdoctoral U.S. research scientists, Instructors**, and Academic Staff Researchers** and recently-appointed U.S. junior faculty (at least two years beyond conferral of doctoral degree) for an intensive, mentored research career development experience in a low- or middle-income country (LMIC) leading to an independently funded research career focused on global health. FIC invites applications from early-career investigators from any health related discipline who propose career development activities and a research project that is relevant to the health priorities of the LMIC.
See the guidelines for additional eligibility criteria
Application Receipt/Submission Date(s):  March 7, 2019, March 6, 2020 by 5:00 PM local time of applicant organization.
Guidelines:
https://grants.nih.gov/grants/guide/pa-files/PAR-18-540.html




NIH K Career Development Award resource webpage:
http://med.stanford.edu/rmg/funding/nih_kawards.html


Funding Opportunities for postdoctoral and medical fellows:
Foundations/associations, NIH, NSF more >>

 

 

Career development award for investigators in institutions in lmic countries

 




NIH Emerging Global Leader Award (K43) (PAR-17-001)

John E. Fogarty International Center (FIC)
National Cancer Institute (NCI)
National Human Genome Research Institute (NHGRI)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
To provide research support and protected time to a research scientist from a low- or middle-income country (LMIC) with a junior faculty position at an LMIC academic or research institution. This intensive, mentored research career development experience is expected to lead to an independently funded research career. This Funding Opportunity Announcement (FOA) invites applications from LMIC scientists from any health related discipline that propose career development activities and a research project that is relevant to the health priorities of their country under the mentorship of a LMIC and U.S. mentor.
See clarification re: country eligibility:
NIH Notice NOT-TW-17-002.
See revised PI eligibility requirements: NIH Notice NOT-TW-17-004
Remaining application Receipt/Submission Date(s): November 7, 2018
Guidelines:
http://grants.nih.gov/grants/guide/pa-files/PAR-17-001.html

 

 

 

conference and scientific meeting funding


 

NIH Support for Conferences and Scientific Meetings (Parent R13) PAR-18-648
Standard R13 deadlines: April 12, Aug. 12, Dec. 12
Expiration date: Jan. 8, 2021
Program announcement:
https://grants.nih.gov/grants/guide/pa-files/PA-18-648.html
Table of program/institute contacts:
https://grants.nih.gov/grants/guide/contacts/parent_R13_U13.html

Per NIH Notice- NOT-CA-16-070:This recent notice clarifies the above Parent R13 FOA can be used for funding for conferences and scientific meetings relevant to the scientific mission of the NCI's Center for Global Health, which is to help reduce the global burden of cancer. Conferences and scientific meetings may address emerging opportunities in global cancer research and/or create sustainable international cancer research partnerships. Conferences that focus on regionally-relevant cancers; cancers with an atypical phenotype, incidence, or biology; or cancers associated with chronic infection including HIV-associated malignancies are encouraged to apply. This list is not meant to be exhaustive and one conference may cover more than one aspect. Conferences and scientific meetings proposing to incorporate one or more of the following scientific disciplines are of particular interest to NCI's Center for Global Health:
(1) cancer prevention and control;
(2) cancer detection and diagnosis, including anatomic and clinical pathology;
(3) dissemination and implementation research;
(4) health surveillance including cancer registries; and
(5) cancer-relevant informatics and mobile Health (mHealth).

 

 

 

Dissemination and implementation research in health

 

 

Dissemination and Implementation Research in Health (R03) PAR-13-056
Multiple participating institutes, including Fogarty International Center (FIC)*
Dissemination research is the scientific study of targeted distribution of information and intervention materials to a specific public health or clinical practice audience. The intent is to understand how best to spread and sustain knowledge and the associated evidence-based interventions.
Implementation research is the scientific study of the use of strategies to adopt and integrate evidence-based health interventions into clinical and community settings in order to improve patient outcomes and benefit population health.
*For specific information about FIC priorities for dissemination and implementation research refer to the FIC website: http://www.fic.nih.gov/About/Pages/Strategic-Plan.aspx
Standard R03 deadlines: Feb. 16, June 16, Oct. 16
Standard AIDS-related deadlines: May 7, Sept. 7, Jan. 7
Expiration date: May 8, 2019
http://grants.nih.gov/grants/guide/pa-files/PAR-16-237.html


 

 

HIV

 

 


Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low and Middle- Income Countries (R21 Clinical Trial Optional)
(PAR-18-732)

FIC, NCI, NICHD, NIMH, OBSSR
Non-U.S. High Income Country Institutions are not eligible as the primary partner for the LMIC Institution, but may be included as consultants, especially if they present special opportunities for the proposed research. An LMIC-U.S. or LMIC-LMIC partnerships between institutions are eligible.
Deadline: Aug. 1, 2018
http://grants.nih.gov/grants/guide/pa-files/PAR-18-732.html

 


Detection of HIV for Self-Testing (R61/R33) (PAR-17-471)
National Institute of Allergy and Infectious Diseases
National Institute of Mental Health
Exploratory/Developmental Phased Award
To support bi-phasic developmental, discovery-driven, or hypothesis-driven research focused on innovative strategies to detect HIV either within the first two weeks of infection or to monitor viral rebound after stopping or developing resistance to antiretroviral therapy.
Application Receipt/Submission Date(s): December 6, 2018, and December 6, 2019
http://grants.nih.gov/grants/guide/pa-files/PAR-17-471.html

 

 

Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43) (PAR-16-279)
FIC, NCI, NIAAA, NIDA, NIMH
An application should focus the proposed training program to strengthen research capacity in a defined HIV scientific area at a specific LMIC institution or at LMIC sites in an established HIV research network. LMIC institutions now have the options to apply to the D43 FOA or to the D71 (planning grant) FOA. Another change is that the beneficiary of the training supported through this FOA is expanded to include LMIC sites in an established HIV research network.
Remaining Application Receipt/Submission Date(s):  August 23, 2018
http://grants.nih.gov/grants/guide/pa-files/PAR-16-279.html

 

Planning Grant for Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D71) (PAR-16-281)
FIC, NCI, NIAAA, NIDA, NIMH
These applications must propose a plan to develop a research training program and the subsequent application that will be submitted in response to the companion D43 FOA (PAR-16-279). The planned research training program should strengthen research capacity in a defined high priority HIV scientific area (NOT-OD-15-137) at a specific LMIC institution or at LMIC sites in an established HIV research network.
Remaining Application Receipt/Submission Date(s):  August 23, 2018
http://grants.nih.gov/grants/guide/pa-files/PAR-16-281.html

 

Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11) (PAR-16-280) *reissued*
FIC, NCI, NIAAA, NIDA, NIMH
This FOA encourages collaborative applications from U.S. and LMIC institutions to support training to achieve technical, administration and financial management expertise required for one of the six research infrastructure functions considered critical to a successful high quality research environment: 1) Research administration and management; 2) Research integrity oversight; 3) Ethical review of research for the protection of human subjects; 4) Laboratory animal welfare oversight; 5) Health sciences library and information services; and 6) Information and communications technology systems (ICT) for research
Remaining Application Receipt/Submission Date(s): August 23, 2018
http://grants.nih.gov/grants/guide/pa-files/PAR-16-280.html


 




INdia-u.s. vaccine  action program



Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03) (PA-16-163)
National Institute of Allergy and Infectious Diseases
This initiative offers to support VAP research activities and encourages research leading to the development of new and improved vaccines and related products, and technologies to combat infectious diseases of importance in India, the U.S., the South Asian region and globally.
NOTE: While applicants must provide evidence of ongoing or proposed scientific collaborations specific to the research proposed in the grant application, this initiative will not require joint application, review and funding of applications by the U.S. and India as was required in previous VAP-supported research projects. Standard NIH application and review procedures will be followed. NIAID will fund the grants supported by this FOA.
Standard R03 small grant deadlines: Feb. 16, June 16, Oct. 16
Standard AIDS-related deadlines: May 7, Sept. 7, Jan. 7
Expiration date: May 8, 2019
http://grants.nih.gov/grants/guide/pa-files/PA-16-163.html


 



INfectious diseases



NIH NIAID International Research in Infectious Diseases, including AIDS (R01) (PAR-17-142)
National Institute of Allergy and Infectious Diseases
Eligibility: This FOA encourages applications from organizations/institutions in eligible foreign countries that propose research related to infectious diseases that are of interest/importance to that country. Collaborations with investigators in the U.S. are encouraged but not required.
Topics of interest for this program are limited to research on infectious diseases, including but not limited to: tuberculosis; malaria; influenza; HIV/AIDS; sexually transmitted diseases; diarrheal, respiratory, and enteric diseases; viral hemorrhagic fevers; viral encephalitides; other viral diseases, parasitic diseases; vectors and vector-borne diseases, emerging and/or re-emerging infectious (including but not limited to Zika virus and yellow fever), and development of drug resistance that are of public health significance within the applicant country.
Development of basic, immunological, microbiological, biostatistical, epidemiological, data management, and clinical research capacity is encouraged
Remaining application Receipt/Submission Date(s):  May 22, 2018; May 22, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-17-142.html

 


Planning for Non-Communicable Diseases and Disorders Research Training Programs in Low and Middle Income Countries (D71)
(PAR-17-097)

John E. Fogarty International Center
Eligibility: This FOA invites submissions from low- and middle-income country (LMIC) institution(s) with existing research and research training capacity in chronic, non-communicable diseases and disorders (NCDs). These institutions must propose to assess needs and develop a plan for a research training program within the LMIC(s) that will further strengthen the capacity of LMIC individuals, institution(s) and country(ies) to identify NCD priorities and conduct NCD research across the lifespan.
The application from the LMIC institution(s) may include collaboration with United States (U.S) institutions and other LMIC institutions as justified and appropriate.
Remaining application Receipt/Submission Date(s): March 14, 2019
http://grants.nih.gov/grants/guide/pa-files/PAR-17-097.html

 

 

Global Infectious Disease Research Training Program (D43) (PAR-17-057)
John E. Fogarty International Center
National Institute of Allergy and Infectious Diseases
Eligibility: Applications may be submitted by an eligible foreign institution in a LMIC with a collaborating U.S. institution or by an eligible domestic (U.S.) institution that demonstrates collaborations with an LMIC institution named in the application by documented joint publications, grants or previous research training activities.
Application Receipt/Submission Date(s): July 26, 2018; July 25, 2019
Guidelines:
http://grants.nih.gov/grants/guide/pa-files/PAR-17-057.html

 



Planning Grant for Global Infectious Disease Research Training Program (D71) (PAR-17-058)

John E. Fogarty International Center
Eligibility: Only higher education institutions in LMICs are eligible to apply.
Application Receipt/Submission Date(s): July 26, 2018; July 25, 2019
Guidelines:
http://grants.nih.gov/grants/guide/pa-files/PAR-17-058.html

 

 

Modeling of Infectious Disease Agent Study Research Projects (R01) (PA-16-107)
National Institute of General Medical Sciences
In addition to national response strategies, local, community, regional, and global plans should be considered.
Standard R01 deadlines: Feb. 5, June 5, Oct. 5
Standard AIDS-related deadlines: May 7, Sept. 7, Jan. 7
Expiration date: May 8, 2019
http://grants.nih.gov/grants/guide/pa-files/PA-16-107.html

 



SIMULATION MODELING and systems science to address HEALTH DISPARITIES

 



Simulation Modeling and Systems Science to Address Health Disparities (R01-Clinical Trial Not Allowed) PAR-18-331
NIMHD, NCI, NHLBI*, NIA, NIDCD, NIDA, NIMH, NLM, ODP, OBSSR, NIAAA
*NHLBI topics include:
Studies modeling the magnitude and/or burden of HLBS diseases and disorders in global populations; simulation modeling and systems science studies to characterize global health inequities in heart, lung, blood and/or sleep disorders; modeling studies aimed at improving the quality of care among global populations in various settings (e.g., rural, minority, low literacy and other underserved populations) for HLBS diseases and disorders.
Comparison studies of HLBS diseases and disorders between US and global populations simulating possible scenarios that could lead to significant reductions in disease burden for heart, lung, blood, and/or sleep disorders.
Remaining application receipt dates: June 6, 2018; January 8, 2019; June 7, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-18-331.html




 

 

MObile health




Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21-Clinical Trial Optional) (PAR-18-242)
John E. Fogarty International Center
National Cancer Institute
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
The overall goal of the FOA is to contribute to the evidence base for the use of mobile technology to improve clinical outcomes and public health while building research capacity in LMICs and establishing research networks in this area. Applicants are required to propose partnerships between at least one U.S. institution and one LMIC institution and the proposed research plan should strengthen the mHealth research capabilities at the LMIC institution.
Remaining Application Receipt/Submission Date(s):  August 31, 2018
Program announcement
https://grants.nih.gov/grants/guide/pa-files/PAR-18-242.html

 

 

 



Neuroscience

 

 

Global Brain and Nervous System Disorders Research Across the Lifespan (R21) (PAR-17-313)
FIC, NEI, NIA, NIDCD, NIDCR, NIEHS, NIMH, NINDS, ODS & new: NICHD
R21 exploratory/developmental award mechanism
Research on neurological, mental, behavioral, alcohol and substance use disorders may span the full range of science from basic to implementation research.
Scientists in the United States (U.S.) or upper-middle income countries (UMICs) are eligible to partner with scientists in LMIC institutions.
Scientists in upper middle-income LMICs (UMICs) are also eligible to partner directly with scientists at other LMIC institutions with or without out a US partner.
Application Receipt/Submission Date(s): November 7, 2018; November 7, 2019
http://grants.nih.gov/grants/guide/pa-files/PAR-17-313.html

 

Global Brain and Nervous System Disorders Research Across the Lifespan (R01) (PAR-17-314)
FIC, NEI, NIA, NIDCD, NIEHS, NIMH, NINDS, ODS & new: NICHD
See above description
Application Receipt/Submission Date(s): November 7, 2018; November 7, 2019
http://grants.nih.gov/grants/guide/pa-files/PAR-17-314.html

 


 

Pulmonary non-tuberculous myobacterial infections

 

 

Notice of NIAIDs Interest in Biomedical Research in non-AIDS associated, Pulmonary Non-Tuberculous Mycobacterial (NTM) Infections
NIH Notice NOT-AI-17-016 >>
National Institute of Allergy and Infectious Diseases

Pulmonary non-tuberculous mycobacterial infections are increasing and are now the dominant mycobacterial infections in the US and much of the developed world, far surpassing tuberculosis. In order to stimulate and facilitate the development of knowledge, drugs and diagnostics, and determine whether a vaccine or other immune interventions are feasible, additional information on the disease process and its effects are needed. NIAID is issuing this notice to highlight its interest in receiving grant applications focused on basic and translational research in non-AIDS associated pulmonary non-tuberculous mycobacterial (NTM) infections. See the above notice for areas of interest.

Possible funding opportunities that can be used to pursue these research activities include:

You are strongly encouraged to discuss your research project with the NIH scientific program official for the institute which most closely relates to your project.

NIH NIAID Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01) PAR-16-254
National Institute of Allergy and Infectious Diseases (NIAID)
Remaining deadline: January 11, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-16-254.html

NIH Small Research Grant Program (Parent R03-Clinical Trials not allowed) (PA-18-488)
Multiple participating institutes
Standard R03 small grant deadlines: Feb. 16, June 16, Oct. 16
Program announcement:
https://grants.nih.gov/grants/guide/pa-files/PA-18-488.html
Table of institute/center program officials:
https://grants.nih.gov/grants/guide/contacts/parent_R03.html

NIH Exploratory/Developmental Research Grant Program (Parent R21-Clinical Trial not allowed) (PA-18-489)
Multiple participating institutes
Standard R21 exploratory/developmental grant deadlines: Feb. 16, June 16, Oct. 16
Program announcement:
https://grants.nih.gov/grants/guide/pa-files/PA-18-489.html
Table of institute/center program officials:
https://grants.nih.gov/grants/guide/contacts/parent_R21.html

 


NIH Research Project Grant (Parent R01-Clinical Trial Not Allowed) (PA-18-484)
Multiple participating institutes
Eligibility: faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver)
Standard R01 deadlines: Feb. 5, June 5, Oct. 5
Program announcement:
https://grants.nih.gov/grants/guide/pa-files/PA-18-484.html
Table of institute/center program officials:
https://grants.nih.gov/grants/guide/contacts/parent_R01.html

 

 

 

 

 

tobacco use and hiv in low and middle income countries

 


Tobacco Use and HIV in Low and Middle Income Countries (R21 Clinical Trial Optional) (PAR-18-022)
National Cancer Institute
National Institute on Drug Abuse
R21 exploratory/developmental award mechanisms
Applications are encouraged that focus on the development and evaluation of tobacco cessation interventions tailored to HIV positive populations, including those with co-morbidities such as tuberculosis (TB), in low-resource settings in LMICs. This FOA provides funding for research planning, intervention delivery, and follow-up activities.
Eligibility: U.S.academic institutions and foreign institutions are eligible (see criteria)

Revised remaining Application Receipt/Submission Date(s): November 1, 2018; April 4, 2019, November 1, 2019
http://grants.nih.gov/grants/guide/pa-files/PAR-18-022.html

 

 

Tobacco Use and HIV in Low and Middle Income Countries (R01 Clinical Trial Optional) (PAR-18-023)
National Cancer Institute
National Institute on Drug Abuse
Applications are encouraged that focus on the development and evaluation of tobacco cessation interventions tailored to HIV positive populations, including those with co-morbidities such as tuberculosis (TB), in low-resource settings in LMICs. This FOA provides funding for research planning, intervention delivery, and follow-up activities.
Eligibility: U.S.academic institutions and foreign institutions are eligible (see criteria)

Revised remaining Application Receipt/Submission Date(s): November 1, 2018; April 4, 2019, November 1, 2019
http://grants.nih.gov/grants/guide/pa-files/PAR-18-023.html

 

 


 

zika virus

 

 

NIH Fogarty International Center: Zika Virus Information and Resources
NIH FIC webpage >> containing links to numerous articles.

 

 



NIH zika virus (zikv) complications (r21) pa-18-048

 

 

NIH Zika Virus (ZIKV) Complications (R21-Clinical Trial Optional) (PA-18-048)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Eye Institute
National Institute of Allergy and Infectious Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Neurological Disorders and Stroke
Standard R21 exploratory/developmental deadlines beginning: June 16, Oct. 16, Feb. 16
Standard AIDS related deadlines: May 7, Sept. 7, Jan. 7
Expiration date: Jan. 8, 2020
https://grants.nih.gov/grants/guide/pa-files/PA-17-085.html




 

NIAID-high priority zika virus research areas

 

Per notice NOT-AI-16-026 NIAID highlights its interest in research on, and product development for, Zika Virus.
See this notice for suggested topic areas.

NIAID suggests PIs can use these RFAs/PAs to pursue the research areas:

 

NIH investigator-initiated RFPs


You are strongly encouraged to discuss your research project with the institute’s scientific program official.

NIH Research Project Grant (Parent R01-Clinical Trial Not Allowed) (PA-18-484)
Multiple participating institutes
Standard R01 deadlines: Feb. 5, June 5, Oct. 5
Program announcement:
https://grants.nih.gov/grants/guide/pa-files/PA-18-484.html
Table of institute/center program officials:
https://grants.nih.gov/grants/guide/contacts/parent_R01.html

NIH Exploratory/Developmental Research Grant Program (Parent R21-Clinical Trial not allowed) (PA-18-489)
Multiple participating institutes
Standard R21 exploratory/developmental grant deadlines: Feb. 16, June 16, Oct. 16
Program announcement:
https://grants.nih.gov/grants/guide/pa-files/PA-18-489.html
Table of institute/center program officials:
https://grants.nih.gov/grants/guide/contacts/parent_R21.html

NIH Small Research Grant Program (Parent R03-Clinical Trials not allowed) (PA-18-488)
Multiple participating institutes
Standard R03 small grant deadlines: Feb. 16, June 16, Oct. 16
Program announcement:
https://grants.nih.gov/grants/guide/pa-files/PA-18-488.html
Table of institute/center program officials (this reflects the previous FOA)
https://grants.nih.gov/grants/guide/contacts/parent_R03.html




NHLBI recommendations for zika virus funding

 


 

NHLBI recommends that PIs submit their proposals through these existing funding opportunities:

Notice: NOT-HL-16-466 (Nov. 17, 2016): http://grants.nih.gov/grants/guide/notice-files/NOT-HL-16-466.html
NHLBI is issuing this Notice to encourage individuals interested in research to evaluate the risk of and clinical impact of potential transmission of the Zika virus by transfusion to submit their applications using the following NIH Funding Opportunity Announcements.


Topics:
Research interests include but are not limited to:

    • characterization of the prevalence and recent or seasonal incidence of the virus among blood donors in different geographical regions;

    • quantitation and dynamics of the evolution of viremia and viral persistence and infectivity in blood compartments over the course of infection in blood donors; transmissibility studies in relevant animal models;

    • dynamics of viremia and immune responses post transfusion and clinical consequences of infection in pediatric and adult recipients with various underlying diseases and indications for transfusion;

    • development of enhanced performance Zika virus screening and confirmatory assays for viral nucleic acids, antigens and antibodies including laboratory based and point of care assays;

    • transfusion-transmission studies; and evaluations of potential strategies to reduce or prevent Zika virus transmission by blood transfusion.


NIH Research Project Grant (Parent R01-Clinical Trial Not Allowed) (PA-18-484)
Multiple participating institutes
Standard R01 deadlines: Feb. 5, June 5, Oct. 5
Program announcement:
https://grants.nih.gov/grants/guide/pa-files/PA-18-484.html
Table of institute/center program officials (this reflects the previous FOA)
https://grants.nih.gov/grants/guide/contacts/parent_R01.html



NIH NHLBI Selected Topics in Transfusion Medicine (R01) PAR-18-126

National Heart, Lung and Blood Institute (NHLBI)
Eligibility: faculty wlith PI eligibility and CE faculty (with an approved CE faculty PI waiver)
Remaining Deadlines: October 5, 2018; February 5, 2019; October 5, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-18-126.html
*NHLBI program contact: check witih the scientific program contact listed below to discuss your project



NIH NHLBI Selected Topics in Transfusion Medicine (R21) PAR-18-132
National Heart, Lung and Blood Institute (NHLBI)
Eligibility: faculty wlith PI eligibility and CE faculty (with an approved CE faculty PI waiver)
Remaining deadlines: October 16, 2018; February 16, 2019; October 16, 2019
https://grants.nih.gov/grants/guide/pa-files/PAR-18-132.html

**NHLBI program contact: check witih the scientific program contact listed below to discuss your project



NHLBI Scientific Program Contacts

Investigators interested in developing applications for Zika virus-related blood supply safety and transfusion research are strongly encouraged to discuss their ideas with the NHLBI contacts listed below:

Division of Blood Diseases and Resources
Simone Glynn, M.D., M.P.H.
Telephone: 301-435-0065
Email: glynnsa@nhlbi.nih.gov

Small Business Coordinator
Jennifer Shieh, Ph.D.
Telephone: 301-496-2149
Email: nhlbi_sbir@mail.nih.gov

 

 

 

Nichd, ninds, nidcr, niaid-recommendations for zika virus funding

 

NICHD, NINDS, NIDCR, NIAID- Zika Virus as it relates to the mother-infant dyad and sequelae of infection.

NIH Notice (NOT-HD-16-004) interest in research on Zika virus (ZIKV) as it relates to the mother-infant dyad and sequelae of infection.

Priority Research Areas: see below for priority Zika-related research areas >>

Existing funding opportunities to use to submit your proposals:
The NIH notice includes the following possible funding opportunities that can be used.

Eligibility: Stanford faculty with PI eligibility (UTL, MCL and NTL-Research) and CE faculty (with an approved CE faculty PI waiver >>)

NIH Research Project Grant (Parent R01-Clinical Trial Not Allowed) (PA-18-484)
Multiple participating institutes
Standard R01 deadlines: Feb. 5, June 5, Oct. 5
Program announcement:
https://grants.nih.gov/grants/guide/pa-files/PA-18-484.html
Table of institute/center program officials (this reflects the previous FOA)
https://grants.nih.gov/grants/guide/contacts/parent_R01.html

 

NIH Exploratory/Developmental Research Grant Program (Parent R21-Clinical Trial not allowed) (PA-18-489)
Multiple participating institutes
Standard R21 exploratory/developmental grant deadlines: Feb. 16, June 16, Oct. 16
Program announcement:
https://grants.nih.gov/grants/guide/pa-files/PA-18-489.html
Table of institute/center program officials (this reflects the previous FOA)
https://grants.nih.gov/grants/guide/contacts/parent_R21.html




NIH NICHD Advancing Understanding, prevention, and management of Infections Transmitted from Women to their Infants (R21) PAR-16-031

Standard R21 deadlines: Feb. 16, June 16, Oct. 16
AIDS-related deadlines: May 7, Sept. 7, Jan. 7
Expiration date: Sept. 8, 2019
http://grants.nih.gov/grants/guide/pa-files/PA-16-031.html



NIH NICHD Advancing Understanding, prevention, and management of Infections Transmitted from Women to their Infants (R01) PAR-16-032

Standard R01 deadlines: Feb. 5, June 5, Oct. 5
AIDS-related deadlines: May 7, Sept. 7, Jan. 7
Expiration date: Sept. 8, 2019
http://grants.nih.gov/grants/guide/pa-files/PA-16-032.html



NIH Parallel Funding Initiative for Collaborative Research Between Investigators in the USA and in the State of Sao Paulo, Brazil (NOT-TW-16-001)

The National Institute of Health (NIH) and the São Paulo Research Foundation (FAPESP), Brazil, have signed a memorandum of understanding (MOU) to encourage collaborative international research between investigators in the US and in the State of São Paulo.
Per this notice PIs must submit applications using the above investigator-initiated R01 parent grant.
Notice webpage:
http://grants.nih.gov/grants/guide/notice-files/NOT-TW-16-001.html
*Per the notice PIs must submit applications using the above investigator-initiated R01 grant.


NIH NICHD and NIDDK Natural History of Disorders Identifiable by Screening of Newborns (R01) PAR-16-061

Standard R01 deadlines: Feb. 5, June 5, Oct. 5
AIDS-related deadlines: May 7, Sept. 7, Jan. 7
Expiration date: May 8, 2019
http://grants.nih.gov/grants/guide/pa-files/PAR-16-061.html



NIH NIDCR Immune System Plasticity in the Pathogenesis and Treatment of Complex Dental, Oral, and Craniofacial Diseases (R01) PAR-15-192

Standard R01 deadlines: Feb. 5, June 5, Oct. 5
AIDS-related deadlines: May 7, Sept. 7, Jan. 7
Expiration date: Sept. 8, 2018
http://grants.nih.gov/grants/guide/pa-files/PAR-15-192.html


NIH NIDCR Immune System Plasticity in the Pathogenesis and Treatment of Complex Dental, Oral, and Craniofacial Diseases (R21) PAR-15-193

Standard R21 deadlines: Feb. 16, June 16, Oct. 16
AIDS-related deadlines: May 7, Sept. 7, Jan. 7
Expiration date: Sept. 8, 2018
http://grants.nih.gov/grants/guide/pa-files/PAR-15-193.html



NICHD, NINDS, NIDCR, NIAID Areas of High Priority for Zika virus research for the above RFPs:

      • Demonstrate causative role of infection in pregnancy with Zika virus (ZIKV) in the etiology of fetal microcephaly

      • Basic research to understand the ZIKV infection pathogenesis and transmission to the fetus, whether in-utero, postpartum, or breastfeeding

      • Population-based studies to characterize the epidemiology of ZIKV infection in the mother-infant dyad

      • Clinical studies to improve the understanding of the mechanisms and risks of maternal to child transmission of ZIKV

      • Determine the timeline for when and how women transmit ZIKV to the fetus

      • Strategies to prevent transmission of ZIKV to the fetus after infection in the mother

      • Studies to determine the optimal screening for and management of ZIKV infection in pregnant women and in exposed fetuses

      • Studies to understand the mechanisms by which ZIKV affects the developing nervous system and other organ systems

      • Research to develop lab-based or point-of-care diagnosis for ZIKV using saliva as a biofluid

      • Studies to characterize the outcome of viral infection on craniofacial skeletal and dental phenotype with or without microcephaly

      • Studies to understand pregnancy outcomes in women infected with ZIKV

      • Studies to identify sequelae in infants infected with ZIKV as well as potential sequelae in exposed but uninfected infants

      • Strategies to identify neurologic and other manifestations in infants with and without microcephaly such as developmental delays and other neurologic or physical disorders

      • Studies to assess and characterize the natural history and long-term neurodevelopmental consequences of ZIKV infection in children

      • Strategies to identify effective treatments for exposed infants with and without microcephaly as they develop into childhood.

      • Such strategies must take into account cultural acceptance and resources

      • Investigations of mediating and moderating factors affecting variability in neurodevelopmental, behavioral, and socio-emotional impact of ZIKV exposure on infants prenatally and postnatally

      • Develop novel, simple, feasible and cost-effective testing methods and/or strategies for infection screening during pregnancy

      • Develop novel, simple, rapid, feasible and cost effective testing methods and/or strategies for infection screening in the infant

      • Research to develop lab-based or point-of-care diagnosis for ZIKV using saliva as a biofluid

      • Develop culturally sensitive strategies to increase knowledge about the relative efficacy of contraceptive methods, and use that knowledge to plan for pregnancy

      • Strategies to integrate the discussion of risk of ZIKV infection into contraceptive counseling and pre-pregnancy and prenatal care at medical facilities in ZIKV endemic areas

      • Determine long-term implications of ZIKV infection in non-pregnant women and men including impact on fertility and subsequent pregnancy

      • Studies to ascertain if ZIKV is present in reproductive fluids such as semen, cervical mucus, vaginal secretions and/or follicular fluid; persistence of ZIKV in these fluids; and the mechanisms by which ZIKV enters the reproductive tract

      • Studies on effects of ZIKV on in vitro fertilization

      • Studies on whether ZIKV can be transmitted by direct sexual contact or artificial reproductive technology procedures

      • Once causality is demonstrated, studies on vaccine development in pregnant women and children

      • Once causality is demonstrated, development of methods to explain risk of ZIKV infection and risk of harm to the fetus to pregnant women and women who are planning to become pregnant

 

 

 

 




 

foundation and association funding opportunities

 

 

 

American Society of Hematology
ASH Global Research Award

For projects of one year or less, the applicant may request up to $100,000
For projects of more than one year, the applicant may request up to $150,000
Eligibility: Support the hematology-focused careers of ASH members at the trainee and early investigator career stages based in countries other than the United States or Canada.
Types of projects: Hematology research, including basic, translational, patient-oriented, and outcomes-based research; Requests for training at other institutions by trainees or early-career investigators, pilot studies, collaborative projects, and other proposals for career development
Letter of intent (required) deadline: August 31, 2018
Invitation sent to approved applicants: Jan. 2019
Notify your RPM if invited to submit a full proposal:
Institutional representative (RPM/RMG or OSR deadline): April 22, 2019
Full proposal (by invitation only): April 19, 2019
http://www.hematology.org/Global-Research.aspx

 

 

 

 

Conquer Cancer Foundation
(of the American Society of Clinical Oncology)
Global Oncology Young Investigator Award

Total awards: $25K-$30K (5-10 to be awarded)
This is intended for:
(1) researchers in low resource settings on scientific questions specific to those settings
(2) research by investigators in high resource settings on issues in resource-limited settings
(3) collaborative research [high and low resource investigators on question of shared concern
Eligibility: Applicants must:
-have a doctoral degree (including MD, PhD, MD/PhD, DO or equivalent
-apply within the last year of training or the first 2 years of faculty/staff appointment or employment at the time of the grant submission
-not required to have oncology-specific training but should demonstrate an interest in oncology or a related branch of science and be working in an oncology setting
-be a ASCO member or have submitted a membership application with the grant application
See the webpage for eligible US and no-US entities.
Institutional representative (RPM/RMG or OSR) deadline: 5-working days prior to the sponsor's deadline
Full proposal Deadline: Sept. TBA
Guidelines:
https://www.conquer.org/global-oncology-young-investigator-award
Institutional representative for all PIs: your Research Process Manager in RMG (RPM dept. assignment webpage >>)

 

 

The Pew Charitable Trust
Pew Latin American Fellows

Provides support for young scientists from Latin America to receive postdoctoral training in the United States). Applicants must have been awarded a Ph.D. and or M.D. degree by February 2018 but not for more than five years prior to July 14, 2018. Preference will be given to applicants who received their undergraduate and graduate degrees from institutions in Latin America. Applicants may not have had previous postdoctoral training in the United States in excess of 18 months prior to July 14, 2018.Applicants will not be considered if they have completed graduate work with a proposed sponsor. Applicants are required to submit a written statement of intent to return to Latin America See the guidelines for additional details.
Institutional representative (RMG Fellowship Office*) deadline: 5-working days prior to the sponsor's deadline
Deadline: Oct. TBA
http://www.pewtrusts.org/en/projects/pew-latin-american-fellows/program-details
*Institutional representative: Submit your completed PDRF form and application materials to the RMG Fellowship Office per the proposal checklist/guidelines on this webpage >>

 

Conquer Cancer Foundation (of the American Society of Clinical Oncology-ASCO)
International Development and Education Award (IDEA)

Deadline: Jan.
Guidelines:
https://www.conquercancerfoundation.org/international-development-and-education-award
This RFP provides support for early-career oncologists in low- and middle-income countries and facilitates the sharing of knowledge between these oncologists and ASCO members. The program pairs IDEA Recipients with a leading ASCO member “Mentor”, enables Recipients to attend the ASCO Annual Meeting, participate in a post-Meeting visit to their Mentor’s institution, and develop long-term relationships to improve cancer care in their countries. In addition, IDEA Recipients will also receive three years of complimentary ASCO membership, including a subscription to the Journal of Clinical Oncology.
Eligibility:
Applicants must meet the following criteria to qualify for the IDEA and IDEA-PC:
Be a current resident of a country classified by the World Bank as an LMC and have limited resources to attend the ASCO Annual Meeting.
Not have completed more than one academic year of “formal training” (for instance, attended medical school, participated in internships, fellowships, or residency programs) in a country classified by the World Bank as High-Income.
Be a Full Member, Member-in-Training, or International Corresponding member of ASCO; or submit a membership application in one of these categories.
Applicants should be less than 10 years past their oncology training program.
Applicants must be fluent in English (both writing and speaking).
Must have a demonstrated interest in integrating palliative and supportive care into his/her institution. This may be shown by attending courses on the topic, participating in related clinical activities, etc. (IDEA-PC Applicants Only)

 

 

American Cancer Society
Audrey Mars International Fellowships in Clinical Oncology

The purpose of the Audrey Meyer Mars International Fellowship in Clinical Oncology is to provide one year of advanced training in clinical oncology at participating NCI-designated Comprehensive Cancer Center in the United States to qualified physicians and dentists from other countries, particularly countries where advanced training is not readily available.
Training will be conducted at one of the United States National Cancer Institute designated cancer centers participating in the program.
This program provides up to $65,000 annual funding.
Eligibility- see the guidelines
Timeline:
Institutional representative (RPM/RMG) deadline:
Electronic Application deadline:
Paper application deadline:
Guidelines >>




Funding Opportunities for postdoctoral and medical fellows:
Foundations/associations, NIH, NSF more >>

 

 

Emergency Medicine Foundation
International Emergency Medicine Outcomes and Efficacy Research Grant

To promote projects that seek to demonstrate improved patient outcomes in Emergency Departments in low-to middle-income countries (LMICs).Seed grant for up to $10,000 for one year (2 to be awarded)
Eligibility; faculty with PI eligibility and CE faculty (with an approved CE faculty PI waiver)
PIs must have a primary appointment in Emergency Medicine
Institutional representative (RPM/RMG): 5-working days prior to the sponsor's deadline
Deadline: Feb.
https://www.conferenceabstracts.com/cfp2/login.asp?EventKey=GKJONVNC


 

Global Fund for Women
The Global Fund for Women invests in women's groups that advance the human rights of women and girls. We strengthen women-led groups based outside the United States by providing grants ranging from $5,000 to $30,000 per year for operating and project expenses. First-time grant awards generally range from $5,000 to $13,000 per year.
To be eligible for General Support Grants or Travel Grants, a group may only have one proposal of any type under consideration at a given time.
Types of grants: General support grants: Innovation, Strengthening, and Impact Grants (see guidelines for details)
Eligibility: The women's organization must be based in a country outside the United States. We do not fund US based organizations. Its primary focus is advancing women's equality and human rights, with these goals clearly reflected in its activities. It is a group of women working together. We do not accept requests from individuals. It is governed, directed, and led by women. Women must fill all or most of the leadership roles.
Included in the lists of thematic areas is: Advancing Health and Sexual & Reproductive Rights
Deadline: TBA
http://www.globalfundforwomen.org/apply-for-a-grant

 

 


Conquer Cancer Foundation (of the American Society of Clinical Oncology-ASCO)
Long-Term International Fellowship

The Long-term International Fellowship (LIFe) provides early-career oncologists in low- to middle-income countries (LMCs) the support and resources needed to advance their training by deepening their relationship with a mentor in the United States, Canada, or European Union. During the one-year fellowship, the recipients receive valuable training and experience, which they use to effect change in cancer care in their home country.
Amount of funding: The LIFe is a one-year grant totaling $115,000 to pay for personnel, research, and travel expenses including travel to attend the CCF Grants and Awards Ceremony at the ASCO Annual Meeting.
Eligibility:
All of the following criteria must be met in order to qualify for the Long-term International Fellowship:
Be a Full Member or International Corresponding member of ASCO, or a pending member awaiting acceptance.
Be a physician (MD, DO, or international equivalent) who has completed a subspecialty training program (such as hematology-oncology fellowship or radiation oncology residency) or the equivalent.
Be a citizen of a country categorized by the World Bank as Low-Income, Lower-Middle-Income, or Upper-Middle-Income.
Have less than 10 years of experience in the field of oncology.
Have received no more than one year of training in the United States, Canada, or the European Union (for instance, attended medical school, participated in internships, fellowships, research positions or residency programs).
Deadline: Dec. TBA
Guidelines:
https://www.conquercancerfoundation.org/long-term-international-fellowship

 

 

Conquer Cancer Foundation
International Innovation Grant

$20,000 for 1 yr
Eligibility: paid directly to a nonprofit organization or governmental agency in a low-income or middle-income country. The grant may be used by the organization only for the approved, budgeted costs of the research project.
Each grant will have a Principal Investigator who is an ASCO-American Society of Clinical Oncology member, is affiliated with the Grantee Organization, and is a resident of the low-income or middle-income country.
Letter of intent (required) deadline: July
Full application deadline: Oct.
https://www.conquercancerfoundation.org/grants-awards

 

 

 



 

Miscellaneous resources

 

Stanford Center for Innovation in Global Health
http://globalhealth.stanford.edu/

Society for Neuroscience
Global Funding Sources resource webpage >>


Stanford Woods Institute for the Environment
Water, Health and Development Program

http://water.stanford.edu/





 

center for disease control (cdc)



To search for CDC funding opportunities, go to the Grants.gov Advanced Search webpage:
http://www.grants.gov/web/grants/search-grants.html
Search by keyword-enter: CDC
Eligibility: Stanford faculty with PI eligibility with UTL, MCL, NTL-Research appointments
and CE Faculty with an approved CE Faculty PI waiver>>



 

U.s. agency for international development (USAID)

 

 

Grantsgov Search Tool
Click on the "browse agencies" tab on this webpage and then select
"Agency for International Development" to view their current announcements:
http://www.grants.gov/web/grants/home.html



 

Stanford resources

 

 

Institutional Representatives
*Medicine: RPM Assignments by department webpage >>
You are encouraged to alert your RPM 3-4 weeks prior to any sponsor’s deadline so that your budget can be completed no later than 10 days prior to the sponsor’s deadline. Per the above policy, the internal proposal/institutional representative deadline is the complete by date** and not the “let’s get started date”. [**5 working days prior to the sponsor’s deadline your fully approved and completed PDRF form and application materials must be provided to your RPM/RMG or OSR.]
*Other schools: Download the Pre-award OSR department assignments on this DoResearch webpage >>


Internal proposal deadline policy, best practices and FAQs for grants, contracts, subcontracts and fellowships:
School of Medicine PIs
SoM internal proposal deadline policy and FAQs: webpage >>.
CE faculty you must submit and receive approval for a CE faculty PI waiver through your RPM prior to submitting a pre-application per these instructions >>
Other schools
Office of Sponsored Research (OSR) internal deadline policy and FAQs: DoResearch webpage >>

Stanford Research Development Office (SRDO), School of Medicine
The SRDO is an additional and optional resource for School of Medicine faculty applying for grants. Its priorities for grants include large center or program project grants, grants on topics aligned with the Dean's initiatives, and junior faculty, i.e., assistant professors, applying for their first major research grants, such as NIH R01 and similar grants. SRDO's services will include identification of funding opportunities, editing of proposals, project management and assembly of large proposals, interfacing with sponsors and university central offices, and promoting collaborations. The contacts are Michael K. Helms, PhD, MBA (mkhelms@stanford.edu, 650-723-4526), Director of SRDO, and Sandra Holden, PhD (srholden@stanford.edu, 650-724-5345), Grant Development Officer.
SRDO website (SUNET ID required for access)
https://srdo.spectrum.stanford.edu/


The Office of Faculty Development and Diversity (OFDD)-School of Medicine
The Office of Faculty Development and Diversity (OFDD) is a unique resource for School of Medicine faculty applying for grants. Its priorities include junior faculty, i.e., instructors and assistant professors, applying for their first major research grants, such as the NIH career development K awards, R01 and similar grants. In addition to workshops on grantsmanship and transition to independence, OFDD services include individual mentorship and one-on-one advising designed to edit proposals, define, develop and elucidate scientific questions related to these efforts, establish project management parameters and facilitate and improve manuscript writing. More information on these services can be found on the OFDD website at: http://med.stanford.edu/facultydiversity/faculty-development or by contacting OFDD directly at: facultydevelopment_som@stanford.edu

 





 




Footer Links: